FDA Approved: OCREVUS — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for OCREVUS (ocrelizumab) submitted by Genentech, Inc., indicating an update to the product labeling under a supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrevus (ocrelizumab)

Snippet

SUPPL AP for OCREVUS (OCRELIZUMAB)